Convergent Therapeutics, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Industry & Market
No industry information available
Funding Information
No funding information available
Headcount Distribution
No headcount data available
Department Breakdown
No department data available
Keywords & Focus Areas
No keywords available
Overview
Convergent Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. The company focuses on developing next-generation targeted radiotherapies, particularly alpha radioantibodies, aimed at treating prostate cancer and other cancers. Their proprietary dual-targeted radionuclide therapies utilize monoclonal antibodies conjugated with alpha-emitting isotopes, such as actinium-225, to effectively target cancer cells while minimizing harm to healthy tissues.
The lead product candidate, CONV01-α, targets prostate-specific membrane antigen (PSMA) and is designed for PSMA-positive castration-resistant prostate cancer. It has shown promising results in Phase 1/2 trials and has received FDA clearance for its IND application, with Phase 2 trials set to begin in 2024. Another candidate, In-111 rosopatamab tetraxetan, is also in Phase 2 development for the same indication. The company employs innovative radioantibody technology to enhance the precision of radiation therapy, focusing on improving treatment outcomes for cancer patients.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to
Compare insights from companies similar to , focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xx | $33234 | 120 | Private | - | 5318 | xxx |
| xxx | $88692 | 121 | Private | - | 8400 | xxxxxxx |
| xxxxx | $88798 | 146 | Private | - | 883 | xxx |
| xx | $30233 | 136 | Private | - | 8476 | xxxxxxxxx |
| xxx | $77851 | 31 | Private | - | 803 | x |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.